RESEARCH TRIANGLE PARK, N.C. -- Icagen, Inc. reported today that on November 12, 2009 the Company received a notification from the NASDAQ Listing Qualifications Department providing notification that, for the last 30 consecutive business days, the bid price of the Company's common stock has closed below the minimum $1.00 per share requirement for continued inclusion under NASDAQ Listing Rule ...

Read the original article
Brought to you by Yahoo! News

Return to Epilepsy News